Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Dantrolene Sodium

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,174Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Eagle Announces Laboratory Test Results Demonstrating In Vitro RYANODEX®
    Eagle Announces Laboratory Test Results Demonstrating In Vitro RYANODEX®

    16 Apr 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20200416005156/en

    BUSINESSWIRE
    16 Apr 2020
    Share Share
    Results of Pivotal Phase 3 Reblozyl® (luspatercept-aamt) MEDALIST Trial
    Results of Pivotal Phase 3 Reblozyl® (luspatercept-aamt) MEDALIST Trial

    09 Jan 2020

    // BUSINESS WIRE

    https://www.businesswire.com/news/home/20200109005095/en

    BUSINESS WIRE
    09 Jan 2020
    Share Share
    Enforcement Report - Week of May 8, 2019
    Enforcement Report - Week of May 8, 2019

    08 May 2019

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-may-8-2019-1557294096.pdf

    FDA
    08 May 2019
    Share Share
    Eagle's Announces +ve Results of a Study in Partnership with the U.S. Military
    Eagle's Announces +ve Results of a Study in Partnership with the U.S. Military

    07 May 2019

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20190507005332/en

    BUSINESSWIRE
    07 May 2019
    Share Share
    Eagle Pharmaceuticals Announces Fifth Orange Book Listed Patent for RYANODEX
    Eagle Pharmaceuticals Announces Fifth Orange Book Listed Patent for RYANODEX

    07 Feb 2018

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20180207005194/en/Eagle-Pharmaceuticals-Announces-Orange-Book-Listed-Patent/?feedref=JjAwJuNHiystnCoBq_hl-bQQCakZDujohEJegUyaJwquReQ0P23MrIoWkrUSV24ZevRMp3sIgu8q3wq1OF24lT93qbEzrwa15HGbLqMObxbNWfZlBntHS6jpH5ROLXsTFMkl05DM8ABqeyBleEmzJA==

    BUSINESSWIRE
    07 Feb 2018
    Share Share
    Eagle Pharma shares tank after FDA stiff its application for heat stroke remedy
    Eagle Pharma shares tank after FDA stiff its application for heat stroke remedy

    27 Jul 2017

    // John Carroll ENDPTS

    https://endpts.com/eagle-pharma-shares-tank-after-fda-stiff-arms-its-application-for-heat-stroke-remedy/

    John Carroll ENDPTS
    27 Jul 2017
    Share Share